Le Lézard7m
First Real-World Outcomes Data for ADSTILADRIN® (nadofaragene firadenovec-vncg) to be Presented at 2025 ASCO Genitourinary Cancers Symposium
Ferring Pharmaceuticals announced today three abstracts featuring ADSTILADRIN® (nadofaragene firadenovec-vncg) will be presented at the 2025 American Society of Clinical Oncologists Genitourinary ...
Medscape5d
Could Gene Therapy for RA Soon Be Ready to ‘Take Off’?
Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...
Dallas Observer5d
A New Era of Patient Safety and Hygiene Protocol with AseptiScope’s DiskCover System
Healthcare-associated infections (HAIs) pose a persistent and tremendous threat to patient safety, having claimed 72,000 patients during their hospitalization according to the Centers for Disease ...
precisionmedicineonline6d
Fondazione Telethon Seeking Approval for Wiskott-Aldrich Syndrome Gene Therapy in Europe
Thirty patients have received the gene therapy within a clinical trial and early-access program, and the foundation also hopes to seek approval in the US.
Pharmaceutical Technology6d
Italian charity seeks EMA approval for rescued gene therapy
Telethon Foundation is seeking approval for a gene therapy to treat the rare disease Wiskott-Aldrich syndrome.